Adverum Biotechnologies Inc. buy Chardan Capital
Start price
19.07.24
/
50%
€1.38
Target price
19.07.25
€36.70
Performance (%)
-
End price
20.07.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target raised by analysts at Chardan Capital from $4.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
17.04.25
17.04.25
€29.04
17.04.26
17.04.26
-
20.03.24
20.03.24
Stopped prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
13.08.25
13.08.25
€28.26
13.08.26
13.08.26
-
20.03.24
20.03.24
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
15.05.25
15.05.25
€29.48
15.05.26
15.05.26
-
20.03.24
20.03.24
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.51
19.03.24
19.03.24
€3.68
19.03.25
19.03.25
-8.61%
20.03.25
20.03.25